EU Medicine Authority Concludes GMP Inspection at Kopran's Khopoli Facility
Kopran Ltd 路 Press Release 路 22 Oct 2026, 6:31 pm
EU Medicine Authority Concludes GMP Inspection at Kopran's Khopoli Facility The Medicine Authority European Union (EU) concluded its GMP inspection at Kopran Limited鈥檚 formulation manufacturing facility in Khopoli, conducted between 18th Sep'26 and 23rd Sep'26. The inspection closed with zero critical observations, zero data integrity issues, one major observation, and certain minor observations. The company is actively preparing its compliance responses and plans to submit them to the EU regulatory authorities within a fortnight.
Original exchange filing (PDF)
More announcements from Kopran Ltd
- Reply to Exchange on Volume Movement Letter 路 13 Nov 2026
- The Exchange has sought clarification from Kopran Ltd on November 13, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited. 路 13 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sarvamangal Mercantile Company Ltd 路 13 Nov 2026
- Investor Presentation on Q2 FY 2026-27 Results 路 03 Nov 2026
- Kopran Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 03 Nov 2026
- Unaudited Results for Q2 FY 2026-27 路 03 Nov 2026
- Unaudited results for second quarter ended September 30,2026 路 03 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 03 Nov 2026
